OpenURL Connection Search

Select item for more details and to access through your institution.

A resonance sonorheometry guided dose reduction of plasma transfusion in repetitive hip surgery in a patient with a severe factor XI deficiency: a case report.
Published in:
Anaesthesia Reports, 2024, v. 12, n. 1, p. 1, doi. 10.1002/anr3.12308
By:
- Supthut, H.;
- Peck, P.;
- Hertenstein, B.;
- Delle, C.;
- Winterhalter, M.
Publication type:
Article
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
Published in:
European Journal of Clinical Microbiology & Infectious Diseases, 2013, v. 32, n. 5, p. 679, doi. 10.1007/s10096-012-1794-4
By:
- Maschmeyer, G.;
- Heinz, W.;
- Hertenstein, B.;
- Horst, H.-A.;
- Requadt, C.;
- Wagner, T.;
- Cornely, O.;
- Löffler, J.;
- Ruhnke, M.
Publication type:
Article
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Published in:
Bone Marrow Transplantation, 2001, v. 28, n. 7, p. 705, doi. 10.1038/sj.bmt.1703225
By:
- Hambach, L;
- Eder, M;
- Dammann, E;
- Battmer, K;
- Stucki, A;
- Heil, G;
- Ganser, A;
- Hertenstein, B
Publication type:
Article
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome.
Published in:
Bone Marrow Transplantation, 2000, v. 25, n. 12, p. 1263, doi. 10.1038/sj.bmt.1702429
By:
- Duncker, C;
- Dohr, D;
- von Harsdorf, S;
- Duyster, J;
- Stefanic, M;
- Martini, C;
- Treiber, M;
- Hertenstein, B;
- Novotny, J;
- Arnold, R;
- Heimpel, H;
- Bergmann, L;
- Bunjes, D
Publication type:
Article
Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial.
Published in:
Bone Marrow Transplantation, 1998, v. 22, n. 8, p. 781, doi. 10.1038/sj.bmt.1701434
By:
- Karthaus, M;
- Rosenthal, C;
- Huebner, G;
- Paul, H;
- Elser, C;
- Hertenstein, B;
- Krauter, J;
- Scharmann, T;
- Geissler, R G;
- Heil, G;
- Ganser, A
Publication type:
Article
Immune thyroiditis after transplantation of allogeneic CD34 1 selected peripheral blood cells.
Published in:
Bone Marrow Transplantation, 1997, v. 20, n. 8, p. 697, doi. 10.1038/sj.bmt.1700955
By:
- Karthaus, M.;
- Gabrysiak, T.;
- Brabant, G.;
- Prahst, A.;
- Link, H.;
- Soudah, B.;
- Geissler, R.G.;
- Diedrich, H.;
- Ganser, A.;
- Hertenstein, B.
Publication type:
Article
Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO).
Published in:
Investigational New Drugs, 2015, v. 33, n. 5, p. 1115, doi. 10.1007/s10637-015-0267-x
By:
- Hartmann, Jörg;
- Issels, R.;
- Nicolo, K.;
- Grünwald, V.;
- Hertenstein, B.;
- Papesch, E.;
- Krause, S.;
- Sturm, I.
Publication type:
Article
Diagnostische Maßnahmen bei der Vorbereitung und Durchführung der Knochenmarktransplantation.
Published in:
Journal of Laboratory Medicine / Laboratoriums Medizin, 1994, v. 18, n. 9, p. 349
By:
- Arnold, Renate;
- Bunjes, D.;
- Hertenstein, B.;
- Heimpel, H.
Publication type:
Article
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease.
Published in:
Leukemia (08876924), 2002, v. 16, n. 12, p. 2423, doi. 10.1038/sj.leu.2402712
By:
- Arnold, R;
- Massenkeil, G;
- Bornhäuser, M;
- Ehninger, G;
- Beelen, D W;
- Fauser, A A;
- Hegenbart, U;
- Hertenstein, B;
- Ho, A D;
- Knauf, W;
- Kolb, H J;
- Kolbe, K;
- Sayer, H G;
- Schwerdtfeger, R;
- Wandt, H;
- Hoelzer, D
Publication type:
Article
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.
Published in:
2000
By:
- Posthuma, E F M;
- Falkenburg, J H F;
- Apperley, J F;
- Gratwohl, A;
- Hertenstein, B;
- Schipper, R F;
- Oudshoorn, M;
- Biezen, JH v;
- Hermans, J;
- Willemze, R;
- Roosnek, E;
- Niederwieser, D;
- Posthuma, E F;
- Falkenburg, J H;
- Biezen, J H
Publication type:
journal article
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation.
Published in:
1999
By:
- Eder, M;
- Battmer, K;
- Kafert, S;
- Stucki, A;
- Ganser, A;
- Hertenstein, B
Publication type:
journal article
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).
Published in:
2017
By:
- Nagel, Gabriele;
- Weber, D.;
- Fromm, E.;
- Erhardt, S.;
- Lübbert, M.;
- Fiedler, W.;
- Kindler, T.;
- Krauter, J.;
- Brossart, P.;
- Kündgen, A.;
- Salih, H.;
- Westermann, J.;
- Wulf, G.;
- Hertenstein, B.;
- Wattad, M.;
- Götze, K.;
- Kraemer, D.;
- Heinicke, T.;
- Girschikofsky, M.;
- Derigs, H.G.
Publication type:
journal article
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation.
Published in:
Journal of Neurology, 2000, v. 247, n. 5, p. 376
By:
- Comi, G.;
- Kappos, L.;
- Clanet, M.;
- Ebers, G.;
- Fassas, A.;
- Fazekas, F.;
- Filippi, M.;
- Hartung, H.P.;
- Hertenstein, B.;
- Karussis, D.;
- Martino, G.;
- Tyndall, A.;
- van der Meché, F.G.A.
Publication type:
Article
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patients.
Published in:
European Journal of Haematology, 1998, v. 61, n. 1, p. 7, doi. 10.1111/j.1600-0609.1998.tb01054.x
By:
- Griesshammer, M.;
- Arnold, R.;
- Bangerter, M.;
- Hafner, M.;
- Heinze, B.;
- Hertenstein, B.;
- Heimpel, H.;
- Bunjes, D.
Publication type:
Article
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 11, p. 1459, doi. 10.1038/bmt.2012.45
By:
- Ruutu, T;
- van Biezen, A;
- Hertenstein, B;
- Henseler, A;
- Garderet, L;
- Passweg, J;
- Mohty, M;
- Sureda, A;
- Niederwieser, D;
- Gratwohl, A;
- de Witte, T
Publication type:
Article
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 8, p. 1045, doi. 10.1038/bmt.2010.249
By:
- Hübel, K.;
- Fresen, M. M.;
- Salwender, H.;
- Basara, N.;
- Beier, R.;
- Theurich, S.;
- Christopeit, M.;
- Bogner, C.;
- Galm, O.;
- Hartwig, R.;
- Heits, F.;
- Lordick, F.;
- Rösler, W.;
- Wehler, D.;
- Zander, A. R.;
- Albert, M. H.;
- Dressler, S.;
- Ebinger, M.;
- Frickhofen, N.;
- Hertenstein, B.
Publication type:
Article
Prognostic factors in allo-SCT of elderly patients with AML.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 4, p. 545, doi. 10.1038/bmt.2010.145
By:
- Krauter, J.;
- Wagner, K.;
- Stadler, M.;
- Dammann, E.;
- Zucknick, M.;
- Eder, M.;
- Buchholz, S.;
- Mischak-Weissinger, E.;
- Hertenstein, B.;
- Ganser, A.
Publication type:
Article
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications.
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 3, p. 233, doi. 10.1038/sj.bmt.1704784
By:
- Beelen, D W;
- Trenschel, R;
- Casper, J;
- Freund, M;
- Hilger, R A;
- Scheulen, M E;
- Basara, N;
- Fauser, A A;
- Hertenstein, B;
- Mylius, H A;
- Baumgart, J;
- Pichlmeier, U;
- Hahn, J R;
- Holler, E
Publication type:
Article
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2004, v. 34, n. 12, p. 1015, doi. 10.1038/sj.bmt.1704733
By:
- Woywodt, A.;
- Haubitz, M.;
- Buchholz, S.;
- Hertenstein, B.
Publication type:
Article
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
Published in:
Bone Marrow Transplantation, 2003, v. 32, n. 6, p. 593, doi. 10.1038/sj.bmt.1704192
By:
- Einsele, H;
- Bamberg, M;
- Budach, W;
- Schmidberger, H;
- Hess, C F;
- Wörmann, B;
- Meisner, C;
- Straka, C;
- Hebart, H;
- Trümper, L;
- Kröger, N;
- Zander, A R;
- Hegewisch-Becker, S;
- Hossfeld, D K;
- Schmidt, H;
- Müller, P;
- Schlimok, G;
- Hertenstein, B;
- Peest, D;
- Metzner, B
Publication type:
Article
Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2002, v. 29, n. 11, p. 903, doi. 10.1038/sj.bmt.1703583
By:
- Hambach, L.;
- Stadler, M.;
- Dammann, E.;
- Ganser, A.;
- Hertenstein, B.
Publication type:
Article
Aggressive polychemotherapy for acute myelofibrosis.
Published in:
European Journal of Haematology, 1990, v. 44, n. 4, p. 213, doi. 10.1111/j.1600-0609.1990.tb00382.x
By:
- Hertenstein, B.;
- Kurrle, E.;
- Frickhofen, N.;
- Heil, G.;
- Heimpel, H.
Publication type:
Article
T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia.
Published in:
European Journal of Haematology, 1988, v. 41, n. 3, p. 243, doi. 10.1111/j.1600-0609.1988.tb01188.x
By:
- Wiesneth, M.;
- Hertenstein, B.;
- Bunjes, D.;
- Schmeiser, T.;
- Arnold, R.;
- Heimpel, H.;
- Heit, W.
Publication type:
Article
Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults—a single-centre experience.
Published in:
Annals of Hematology, 2008, v. 87, n. 7, p. 551, doi. 10.1007/s00277-008-0466-z
By:
- Buchholz, S.;
- Dammann, E.;
- Koenecke, Ch.;
- Stadler, M.;
- Franzke, A.;
- Blasczyk, R.;
- Bremer, M.;
- Krauter, J.;
- Hertenstein, B.;
- Ganser, A.;
- Eder, M.
Publication type:
Article
Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis.
Published in:
Annals of Hematology, 2004, v. 83, n. 2, p. 107, doi. 10.1007/s00277-003-0791-1
By:
- Khattab, B.;
- Eiz-Vesper, B.;
- Ganser, A.;
- Hertenstein, B.;
- Blasczyk, R.
Publication type:
Article
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
Published in:
Annals of Hematology, 2001, v. 80, n. 12, p. 706, doi. 10.1007/s00277-001-0384-9
By:
- Ottinger, H. D.;
- Müller, C. R.;
- Goldmann, S. F.;
- Albert, E.;
- Arnold, R.;
- Beelen, D. W.;
- Blasczyk, R.;
- Bunjes, D.;
- Casper, J.;
- Ebell, W.;
- Ehninger, G.;
- Eiermann, T.;
- Einsele, H.;
- Fauser, A.;
- Ferencik, S.;
- Finke, J.;
- Hertenstein, B.;
- Heyll, A.;
- Klingebiel, T.;
- Knipper, A.
Publication type:
Article
Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration.
Published in:
2000
By:
- Schöffski, P.;
- Ganser, A.;
- Pascheberg, U.;
- Büsche, G.;
- Gaede, B.;
- Hertenstein, B.;
- Schöffski, P;
- Büsche, G
Publication type:
journal article
A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
Published in:
2008
By:
- Schnittger, S.;
- Bacher, U.;
- Kern, W.;
- Haferlach, T.;
- Hertenstein, B.;
- Haferlach, C.
Publication type:
Letter
BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 881, doi. 10.1002/hon.3196_LBA5
By:
- Borchmann, P.;
- Moccia, A. A.;
- Greil, R.;
- Schneider, G.;
- Hertzberg, M.;
- Schaub, V.;
- Hüttmann, A.;
- Keil, F.;
- Dierlamm, J.;
- Hänel, M.;
- Novak, U.;
- Meissner, J.;
- Zimmermann, A.;
- Mathas, S.;
- Zijlstra, J. M.;
- Fosså, A.;
- Viardot, A.;
- Hertenstein, B.;
- Martin, S.;
- Giri, P.
Publication type:
Article
Toxicities at one year follow‐up in patients with advanced stage classical Hodgkin Lymphoma: results from the randomized phase III HD21 trial by the German Hodgkin Study Group.
Published in:
Hematological Oncology, 2023, v. 41, p. 363, doi. 10.1002/hon.3164_261
By:
- Ferdinandus, J.;
- Moccia, A. A.;
- Greil, R.;
- Hertzberg, M.;
- Schaub, V.;
- Hüttmann, A.;
- Keil, F.;
- Dierlamm, J.;
- Hänel, M.;
- Novak, U.;
- Meissner, J.;
- Zimmermann, A.;
- Mathas, S.;
- Zijlstra, J. M.;
- Fosså, A.;
- Viardot, A.;
- Hertenstein, B.;
- Martin, S.;
- Giri, P.;
- Kamper, P.
Publication type:
Article
CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 41, doi. 10.1002/hon.3163_15
By:
- Illerhaus, G.;
- Ferreri, A.;
- Binder, M.;
- Borchmann, P.;
- Hasenkamp, J.;
- Stilgenbauer, S.;
- Roeth, A.;
- Weber, T.;
- Egerer, G.;
- Ernst, T.;
- Hertenstein, B.;
- Lenz, G.;
- Kobbe, G.;
- Brunnberg, U.;
- Schmidt, C.;
- Kneba, M.;
- Dreyling, M.;
- Möhle, R.;
- Panse, J.;
- Heinicke, T.
Publication type:
Article
Fetal hyperechoic kidneys: Diagnostic considerations and genetic testing strategies.
Published in:
Prenatal Diagnosis, 2024, v. 44, n. 2, p. 222, doi. 10.1002/pd.6517
By:
- Hertenstein, Christine B.;
- Miller, Kristen A.;
- Estroff, Judy A.;
- Blakemore, Karin J.
Publication type:
Article
Knochenmarktransplantation.
Published in:
Der Internist, 2004, v. 45, n. 11, p. 1261, doi. 10.1007/s00108-004-1287-3
By:
- Hertenstein, B.;
- Ganser, A.
Publication type:
Article
Follow Your Nose: Repeat Nasal Bone Evaluation in First‐Trimester Screening for Down Syndrome.
Published in:
Journal of Ultrasound in Medicine, 2023, v. 42, n. 8, p. 1709, doi. 10.1002/jum.16190
By:
- Miller, Kristen A.;
- Sagaser, Katelynn G.;
- Hertenstein, Christine B.;
- Blakemore, Karin J.;
- Forster, Katherine R.;
- Lawson, Cathleen S.;
- Jelin, Angie C.
Publication type:
Article
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41964-y
By:
- Schlenk, R. F.;
- Weber, D.;
- Krzykalla, J.;
- Kindler, T.;
- Wulf, G.;
- Hertenstein, B.;
- Salih, H. R.;
- Südhoff, T.;
- Krauter, J.;
- Martens, U.;
- Wessendorf, S.;
- Runde, V.;
- Tischler, H. J.;
- Bentz, M.;
- Koller, E.;
- Heuser, M.;
- Thol, F.;
- Benner, A.;
- Ganser, A.;
- Döhner, K.
Publication type:
Article
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41964-y
By:
- Schlenk, R. F.;
- Weber, D.;
- Krzykalla, J.;
- Kindler, T.;
- Wulf, G.;
- Hertenstein, B.;
- Salih, H. R.;
- Südhoff, T.;
- Krauter, J.;
- Martens, U.;
- Wessendorf, S.;
- Runde, V.;
- Tischler, H. J.;
- Bentz, M.;
- Koller, E.;
- Heuser, M.;
- Thol, F.;
- Benner, A.;
- Ganser, A.;
- Döhner, K.
Publication type:
Article
A Comparative Review of Methods for T Cell Depletion in the Prophylaxis of Graft-versus-Host Disease.
Published in:
BioDrugs, 1998, v. 9, n. 2, p. 105, doi. 10.2165/00063030-199809020-00003
By:
- Hertenstein, B.;
- Arseniev, L.;
- Novotny, J.;
- Ganser, A.
Publication type:
Article

Found: 37